Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw Transplantation Center experience.

T. Bączkowska,K. Kukuła,E. Nowacka-Cieciura,T. Cieciura,D. Lewandowska,R. Ciecierski,T. Grochowiecki,W. Rowiński,J. Szmidt,M. Durlik,M. Lao

DOI: https://doi.org/10.1016/S0041-1345(01)02842-1

IF: 1.014

2002-03-01

Transplantation Proceedings

Abstract:

What problem does this paper attempt to address?

Postoperative Mortality in Cancer Patients With Preexisting Diabetes

B. Barone,H. Yeh,C. Snyder,Kimberly S Peairs,Kelly B. Stein,R. Derr,A. Wolff,F. Brancati

DOI: https://doi.org/10.2337/dc09-1721

2010-04-01

Diabetes Care

Abstract:OBJECTIVE Diabetes appears to increase risk for some cancers, but the association between preexisting diabetes and postoperative mortality in cancer patients is less clear. Our objective was to systematically review postoperative mortality in cancer patients with and without preexisting diabetes and summarize results using meta-analysis. RSEARCH DESIGN AND METHODS We searched the Medical Literature Analysis and Retrieval System Online (MEDLINE) and Excerpta Medica Database (EMBASE) for articles published on or before 1 July 2009, including references of qualifying articles. We included English language investigations of short-term postoperative mortality after initial cancer treatment. Titles, abstracts, and articles were reviewed by at least two independent readers. Study population and design, results, and quality components were abstracted with standard protocols by one reviewer and checked for accuracy by additional reviewers. RESULTS Of 8,828 titles identified in our original search, 20 articles met inclusion criteria for qualitative systematic review. Of these, 15 reported sufficient information to be combined in meta-analysis. Preexisting diabetes was associated with increased odds of postoperative mortality across all cancer types (OR = 1.85 [95% CI 1.40–2.45]). The risk associated with preexisting diabetes was attenuated but remained significant when we restricted the meta-analysis to models that controlled for confounders (1.51 [1.13–2.02]) or when we accounted for publication bias using the trim and fill method (1.52 [1.13–2.04]). CONCLUSIONS Compared with their nondiabetic counterparts, cancer patients with preexisting diabetes are ∼50% more likely to die after surgery. Future research should investigate physiologic pathways to mortality risk and determine whether improvements in perioperative diabetes care can reduce postoperative mortality.
Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification

Mar Pelayo,Javier Sancho-Sauco,Javier Sánchez-Zurdo,Belén Perez-Mies,Leopoldo Abarca-Martínez,Mª Jesús Cancelo-Hidalgo,Jose Antonio Sainz-Bueno,Juan Luis Alcázar,Irene Pelayo-Delgado

DOI: https://doi.org/10.3390/diagnostics13172785

IF: 3.6

2023-08-29

Diagnostics

Abstract:Background: Ultrasound features help to differentiate benign from malignant masses, and some of them are included in the ultrasound (US) scores. The main aim of this work is to describe the ultrasound features of certain adnexal masses of difficult classification and to analyse them according to the most frequently used US scores. Methods: Retrospective studies of adnexal lesions are difficult to classify by US scores in women undergoing surgery. Ultrasound characteristics were analysed, and masses were classified according to the Subjective Assessment of the ultrasonographer (SA) and other US scores (IOTA Simple Rules Risk Assessment-SRRA, ADNEX model with and without CA125 and O-RADS). Results: A total of 133 adnexal masses were studied (benign: 66.2%, n:88; malignant: 33.8%, n:45) in a sample of women with mean age 56.5 ± 7.8 years. Malignant lesions were identified by SA in all cases. Borderline ovarian tumors (n:13) were not always detected by some US scores (SRRA: 76.9%, ADNEX model without and with CA125: 76.9% and 84.6%) nor were serous carcinoma (n:19) (SRRA: 89.5%), clear cell carcinoma (n:9) (SRRA: 66.7%) or endometrioid carcinoma (n:4) (ADNEX model without CA125: 75.0%). While most teratomas and serous cystadenomas have been correctly differentiated, other benign lesions were misclassified because of the presence of solid areas or papillae. Fibromas (n:13) were better identified by SA (23.1% malignancy), but worse with the other US scores (SRRA: 69.2%, ADNEX model without and with CA125: 84.6% and 69.2%, O-RADS: 53.8%). Cystoadenofibromas (n:10) were difficult to distinguish from malignant masses via all scores except SRRA (SA: 70.0%, SRRA: 20.0%, ADNEX model without and with CA125: 60.0% and 50.0%, O-RADS: 90.0%). Mucinous cystadenomas (n:12) were misdiagnosed as malignant in more than 15% of the cases in all US scores (SA: 33.3%, SRRA: 16.7%, ADNEX model without and with CA125: 16.7% and 16.7%, O-RADS:41.7%). Brenner tumors are also difficult to classify using all scores. Conclusion: Some malignant masses (borderline ovarian tumors, serous carcinoma, clear cell carcinoma, endometrioid carcinomas) are not always detected by US scores. Fibromas, cystoadenofibromas, some mucinous cystadenomas and Brenner tumors may present solid components/papillae that may induce confusion with malignant lesions. Most teratomas and serous cystadenomas are usually correctly classified.

medicine, general & internal
Imaging techniques for the pre-surgical diagnosis of adnexal tumours

Jeroen Kaijser,Vincent Vandecaveye,Christophe M. Deroose,Andrea Rockall,Isabelle Thomassin-Naggara,Tom Bourne,Dirk Timmerman

DOI: https://doi.org/10.1016/j.bpobgyn.2014.03.013

2014-07-01

Abstract:A correct diagnosis of any adnexal mass is essential to triage women to appropriate treatment pathways. Several imaging techniques are available that may be used to provide an assessment of a mass before treatment, such as transvaginal ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography combined with computed tomography. In this chapter, we focus in depth on the role of transvaginal ultrasonography, as current evidence suggests it is the most appropriate initial imaging investigation to identify and characterise any mass if present in women suspected of having adnexal pathology. Subjective assessment by an experienced ultrasound examiner is the optimal approach to diagnose masses, followed by risk models and rules developed by the International Ovarian Tumor Analysis study. A group of tumours has proven difficult to classify with transvaginal ultrasound, and remain a diagnostic challenge for which accurate second-stage tests would be of value. Some studies suggest that magnetic resonance imaging (MRI), compared with other imaging modalities, may play a role in the assessment of this cohort of 'difficult to classify' adnexal masses. These studies, however, did not report quality of transvaginal ultrasonography (i.e. experience level of the examiner) and lacked uniformity in describing the criteria used to define such 'difficult' masses. On the basis of standardised terminology developed by the International Ovarian Tumor Analysis study to describe adnexal masses, as well as prediction models and rules developed in the course of the study, we propose new criteria that we can use to clearly define complex or 'difficult to classify' adnexal masses to focus the role for second-line imaging tests, such as conventional magnetic resonance imaging combined with dynamic contrast-enhanced or diffusion-weighted sequences on masses where further tests other than ultrasonography would be of value.

obstetrics & gynecology
Adnexal Masses in Pregnancy: A Single-Centre Prospective Observational Cohort Study

Jonathan Gaughran,Catherine Magee,Sian Mitchell,Caroline L. Knight,Ahmad Sayasneh

DOI: https://doi.org/10.3390/diagnostics14192182

IF: 3.6

2024-09-30

Diagnostics

Abstract:Objective: To prospectively determine the nature of adnexal masses diagnosed during pregnancy and investigate whether ultrasound was a reliable means of assessing these. Methods: A single-centre prospective observational cohort study was conducted in a large tertiary referral hospital in London. Pregnant women with an adnexal mass detected at or prior to the 12-week routine ultrasound received a detailed ultrasound by a level II ultrasound practitioner at the time of detection; at 12 weeks; 20 weeks; and 6 weeks postpartum. The following outcomes were recorded: subjective impression of the mass; International Ovarian Tumor Analysis simple rules classification; resolution and intervention rate; and the incidence of complications related to the mass. Results: A total of 28,683 pregnant patients were scanned and an adnexal masses was detected in 277 patients, yielding an incidence of 1%. 274 participants were included in the analysis. Subjective impression was as follows: simple 75.9%; dermoid 29.1%; endometrioma 6.6%; haemorrhagic 3.3%; para-ovarian 2.6%; torted simple 0.7%; decidualized endometrioma 0.4%; fibroma 0.4%; theca luteal 0.4%; and borderline ovarian tumour: 0.7%. There was a significant reduction in the volume at each scan (p < 0.0001). Approximately 74.2% of the masses resolved spontaneously. Surgery was performed in 14/274: 2 antenatally, 6 at caesarean section, and 6 postpartum. In 5/247 (2%), there were complications due to the mass. Using IOTA simple rules, 272/274 (99.3%) (p < 0.0001) were classifiable. Only 1/274 (0.4%) had malignant features as per IOTA (p = 0.05). As there were no confirmed malignancies, the accuracy of IOTA simple rules could not be calculated. Conclusions: Adnexal masses in pregnancy are uncommon and the majority spontaneously resolve. Malignancy is rare, as are complications. In the absence of concerns regarding malignancy or cyst accident, there is no need for additional monitoring of these masses during pregnancy.

medicine, general & internal
Imaging Evaluation of Ovarian Masses

Y Y Jeong,E K Outwater,H K Kang,Yong-Yeon Jeong,Eric K. Outwater,Heoun Keun Kang

DOI: https://doi.org/10.1148/radiographics.20.5.g00se101445

2000-09-01

Radiographics

Abstract:Adnexal masses present a special diagnostic challenge, in part because benign adnexal masses greatly outnumber malignant ones. Determination of a degree of suspicion for malignancy is critical and is based largely on imaging appearance. Endovaginal ultrasonography (US) is the most practical modality for assessment of ovarian tumors because it is readily available and has a high negative predictive value. Morphologic analysis of adnexal masses is accurate for identifying masses as either low risk or high risk. The most important morphologic features are non-fatty solid (vascularized) tissue, thick septations, and papillary projections. Color Doppler US helps identify solid, vascularized components in a mass. Spectral Doppler waveform characteristics (eg, resistive index, pulsatility index) correlate well with malignancy but generally add little information to morphologic considerations. Computed tomography can help assess the extent of disease in patients before and after primary cytoreductive surgery. Magnetic resonance (MR) imaging is better reserved for problem solving when US findings are nondiagnostic or equivocal because, although it is more accurate for diagnosis, it is also more expensive. The signal intensity characteristics of ovarian masses make possible a systematic approach to diagnosis. Mature cystic teratomas, cysts, endometriomas, leiomyomas, fibromas, and other lesions can be accurately diagnosed on the basis of T1-weighted, T2-weighted, and fat-saturated T1-weighted MR imaging findings.

radiology, nuclear medicine & medical imaging
Evaluating use of IOTA two‐step strategy to classify adnexal masses identified in pregnancy: pilot study

J. Barcroft,M. Pandrich,S. Del Forno,N. Cooper,K. Linton‐Reid,C. Landolfo,D. Timmerman,S. Saso,T. Bourne

DOI: https://doi.org/10.1002/uog.27707

2024-05-26

Ultrasound in Obstetrics and Gynecology

Abstract:Objectives The primary aim was the validation of benign descriptors (BDs), followed by Assessment of Different NEoplasia's of the adneXa (ADNEX) (when BDs cannot be applied), in a two‐step strategy to classify adnexal masses in pregnancy. The secondary aim was to describe the natural history of adnexal masses in pregnancy. Methods Retrospective analysis of prospectively collected data of women with an adnexal mass on ultrasonography identified during pregnancy between 2017 and 2022. The study was conducted at Queen Charlotte's and Chelsea Hospital, UK. Relevant clinical and ultrasound data were extracted from the medical records and ultrasound software astraia. Adnexal masses were classified and managed according to expert subjective assessment (SA). Ultrasound features were recorded prospectively at the time of ultrasound examination. Borderline ovarian tumours (BOT) were classified as malignant. Benign Descriptors (BDs) were applied to classify adnexal masses, in cases where BDs were not applicable, the ADNEX model (using a risk of malignancy of >10%) was used, in a two‐step strategy. The two‐step strategy was applied retrospectively. The reference standard used was histology (where available) or expert SA at the postnatal ultrasound scan. Results 291 women with a median age of 33 (IQR 29‐36) years presented with an adnexal mass in pregnancy, at a median gestation of 12 (IQR 8‐17) weeks. 267 (267/291, 91.8%) women were followed up to the postnatal period, as 24 women (24/291, 8.2%) were lost to follow up. Based on the reference standard, 4.1% of adnexal masses (11/267) were classified as malignant (all BOTs) and 95.9% (256/267) as benign (41 on histology and 215 based on expert SA at postnatal ultrasound). BDs could be applied to 68.9% of adnexal masses (184/267); of these only one mass (BOT) was misclassified as benign (1/184, 0.5%). ADNEX was used to classify the residual masses (83/267) and misclassified three BOTs as benign (3/10, 30.0%) and 25 benign masses (based on reference standard) as malignant (25/73, 34.2%), 13 (13/25, 52.0%) of these were classified as decidualised endometriomas on expert SA, with confirmed resolution of decidualisation in the postnatal period. The two‐step strategy had a specificity of 90.2%, sensitivity of 63.6%, negative predictive value of 98.3% and positive predictive value of 21.9%. 56 (56/267, 21.0%) women had surgical intervention, four as an emergency during pregnancy (4/267, 1.5%,) and four (4/267, 1.5%) electively during caesarean section. 48 (48/267, 18.0%) women had surgical intervention in the post‐natal period, 11 (11/267, 4.1%) in the first 12 weeks postnatal and 37 >12 weeks (37/267, 13.9%) postnatal. 64 (64/267, 24.0%) adnexal masses resolved spontaneously during follow up. Cyst‐related complications occurred in four women (4/267, 1.5%) during pregnancy (ovarian torsion n=2, cyst rupture n=2) and six (6/267, 2.2%) in the postnatal period (all ovarian torsion). 196 (196/267, 73.4%) had a persistent adnexal mass, including one of the women who had an ovarian torsion and underwent de‐torsion and had a persistent adnexal mass at postnatal ultrasound. Presumed decidualisation occurred in 31.1% (19/61) of endometriomas and had resolved in 89.5% (17/19) by the first postnatal ultrasound scan. Conclusion We found Benign Descriptors apply to most masses in pregnancy, however the small number of malignant tumours in the cohort (4.1%) restricted the evaluation of the ADNEX model, so expert subjective assessment should be used to classify adnexal masses in pregnancy, when BDs do not apply. A larger multicentre prospective study is required to evaluate the use of the ADNEX model to classify adnexal masses in pregnancy. Our data suggests that most adnexal masses can be managed expectantly during pregnancy given a large proportion of masses spontaneously resolved and the low risk of complications. This article is protected by copyright. All rights reserved.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Endometriomas: their ultrasound characteristics

C. Van Holsbeke,B. Van Calster,S. Guerriero,L. Savelli,D. Paladini,A. A. Lissoni,A. Czekierdowski,D. Fischerova,J. Zhang,G. Mestdagh,A. C. Testa,T. Bourne,L. Valentin,D. Timmerman,Caroline Van Holsbeke,Ben Van Calster,Stefano Guerriero,Luca Savelli,Dario Paladini,Andrea Alberto Lissoni,Artur Czekierdowski,Daniela Fischerova,Jing Zhang,Greet Mestdagh,Antonia C Testa,Tom Bourne,Lil Valentin,Dirk Timmerman

DOI: https://doi.org/10.1002/uog.7668

2010-04-20

Ultrasound in Obstetrics and Gynecology

Abstract:OBJECTIVES: To describe the ultrasound characteristics of endometriomas in pre- and postmenopausal patients and to develop rules that characterize endometriomas.METHODS: All patients included in the International Ovarian Tumor Analysis (IOTA) studies were used in our analysis. Patients with an adnexal mass were scanned by experienced sonologists using a standardized research protocol. The gold standard was the histology of the surgically removed adnexal mass. The gray-scale and Doppler ultrasound characteristics of the endometriomas were compared with those of other benign and malignant masses. Based on decision-tree analysis, the existing literature and clinical experience, ultrasound rules for the detection of endometriomas were created and evaluated.RESULTS: Of all 3511 patients included in the IOTA studies, 713 (20%) had endometriomas. Fifty-one per cent of the endometriomas were unilocular cysts with ground glass echogenicity of the cyst fluid. These characteristics were found less often among other benign tumors or malignancies, or among the small set of endometriomas (4%) that were found in postmenopausal patients. Based on the decision-tree analysis, the optimal rule to detect endometriomas was 'an adnexal mass in a premenopausal patient with ground glass echogenicity of the cyst fluid, one to four locules and no papillations with detectable blood flow'. Based on clinical considerations, the following rule: 'premenopausal status, ground glass echogenicity of the cyst fluid, one to four locules and no solid parts' seems preferable.CONCLUSIONS: Several rules had a good ability to characterize endometriomas. The ultrasound characteristics of endometriomas differ between pre- and postmenopausal patients. Masses in postmenopausal women whose cystic contents have a ground glass appearance have a high risk of malignancy.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound

Medica Sam,Monique Raubenheimer,Florin Manolea,Hector Aguilar,Rishi P Mathew,Vimal H Patel,Gavin Low

DOI: https://doi.org/10.1007/s00261-019-02231-9

Abstract:Purpose: MRI is the current imaging gold standard to diagnose adenomyosis, but access is often limited by high costs and availability. Transvaginal ultrasound provides a cost-effective, accurate and readily available alternative. The objective of our study was to determine the diagnostic accuracy of commonly described sonographic findings in predicting uterine adenomyosis. Methods: This retrospective study evaluated 649 MRI studies performed to investigate adenomyosis with a preceding transvaginal ultrasound within 12 months between 2013 and 2018. Two blinded reviewers assessed the presence or absence of six sonographic features: bulky uterus, heterogeneous myometrium, streaky myometrium, myometrial cysts, endometrial-myometrial interface ill-definition, and echogenic linear striations. The sensitivity, specificity, positive and negative predictive values of these features were calculated individually and in combination when compared to MRI as the standard of reference. Results: Adenomyosis was found in 315 (48.5%) cases on MRI. Ultrasound had a high specificity of 91.8% (95% CI 88.4 to 94.6%) but was less sensitive (36.8% (95% CI 31.5 to 42.4%)) for detecting adenomyosis. Comorbid fibroids or focal adenomyosis did not affect diagnostic accuracy. All six variables were significantly more common in patients with adenomyosis compared to those without. Individually, 'bulky uterus' and 'heterogenous myometrium' each demonstrated a mean sensitivity and specificity > 50%. The best dual combined variables were 'bulky uterus' + 'ill definition of the endometrial-myometrial interface' (sensitivity 39%, specificity 91%). The best triple combined variables were 'bulky uterus', 'heterogeneous myometrium' + 'ill definition of the endometrial-myometrial interface' (sensitivity 38%, specificity 93%). Conclusion: Transvaginal ultrasound is highly specific for diagnosing uterine adenomyosis, providing a cost-effective and readily available alternative to MRI.
EP23.19: Diagnostic accuracy of ultrasound scoring systems in differentiating benign versus malignant adnexal masses

G. Khastgir,S. Siwatch,V. Jain,P. Sikka,T. Singh,R. Srinivasan

DOI: https://doi.org/10.1002/uog.28955

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 333-334, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Agreement between frozen section and histopathology to detect malignancy in adnexal masses according to size and morphology by ultrasound

Clarissa de Andrade Amaral,Priscila Grecca Pedrão,Luani Rezende Godoy,Yasmin Medeiros Guimarães,Cassia Arantes Petroni Macedo,Marcia Appel,Guilherme Spagna Accorsi,Jeferson Rodrigo Zanon,Ricardo Dos Reis

DOI: https://doi.org/10.61622/rbgo/2024rbgo63

2024-07-26

Abstract:Objective: Management of suspect adnexal masses involves surgery to define the best treatment. Diagnostic choices include a two-stage procedure for histopathology examination (HPE) or intraoperative histological analysis - intraoperative frozen section (IFS) and formalin-fixed and paraffin-soaked tissues (FFPE). Preoperative assessment with ultrasound may also be useful to predict malignancy. We aimed at determining the accuracy of IFS to evaluate adnexal masses stratified by size and morphology having HPE as the diagnostic gold standard. Methods: A retrospective chart review of 302 patients undergoing IFS of adnexal masses at Hospital de Clínicas de Porto Alegre, between January2005 and September2011 was performed. Data were collected regarding sonographic size (≤10cm or >10cm), characteristics of the lesion, and diagnosis established in IFS and HPE. Eight groups were studied: unilocular lesions; septated/cystic lesions; heterogeneous (solid/cystic) lesions; and solid lesions, divided in two main groups according to the size of lesion, ≤10cm or >10cm. Kappa agreement between IFS and HPE was calculated for each group. Results: Overall agreement between IFS and HPE was 96.1% for benign tumors, 96.1% for malignant tumors, and 73.3% for borderline tumors. Considering the combination of tumor size and morphology, 100% agreement between IFS and HPE was recorded for unilocular and septated tumors ≤10cm and for solid tumors. Conclusion: Stratification of adnexal masses according to size and morphology is a good method for preoperative assessment. We should wait for final HPE for staging decision, regardless of IFS results, in heterogeneous adnexal tumors of any size, solid tumors ≤10cm, and all non-solid tumors >10cm.
The research and application of the optimization technique of continuous annealing line temper mill roll contour

Yan Zhang,Quan Yang,A. He,D. Guo,Xi-jiang Yao

DOI: https://doi.org/10.1109/MACE.2011.5988029

2011-07-15

Abstract:In this article, the writer, having done a research on the stripe shape of the continuous annealing line temper mill, on the base of both the theoretical calculation and the analysis of the production data, established a relevant roll contour supporting optimization model, implemented the optimal calculation with the Hybrid Genetic Algorithm, designed a plan for new roll contour configuration, and analyzed the effect of the 2D varying-thickness theory on the roll gap horizontal rigidity and roll bending control. This article applies the result on the production, improving the stripe shape control effect of the temper mill, reducing roll bending burden.
Role of ultrasonography, magnetic resonance imaging in evaluation of female pelvic masses with histopathological correlation

Pruthvi Malikireddy,Srinivas Reddy Mukku,Nagaraju Baja

DOI: https://doi.org/10.18231/j.pjms.2023.029

2023-04-08

Panacea Journal of Medical Sciences

Abstract:Adnexal mass that can be suspected as malignant with ultrasonography can be diagnosed as benign lesion at magnetic resonance imaging (MRI). This will help in preventing inappropriate surgery. MRI gives additional information on composition of soft-tissue masses using differences in MR relaxation properties in various tissue, which is not seen in ultrasonography. To evaluate pelvic pathology by ultrasound and MRI for differentiating malignant and benign tumors in adnexal masses compared with histopathology Prospective comparative study was carried out among 30 patients with suspected pelvic masses. Thorough clinical history was taken followed by physical examination. Clinically or ultrasonographically detected suspicious pelvic masses were subjected to MRI and correlated histopathologically. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for ultrasonography and MRI with histopathology as gold standard Majority were <50 years. Bleeding per vaginum and pain abdomen were most common symptoms in 20% each. As per ultrasonography, most common diagnosis was adnexal mass in 36%. As per MRI, most common diagnosis was ovarian pathology in 47%. As per histopathology, most common diagnosis was cervical cancer, fibroids and benign ovarian pathologies in 20% of cases each. Sensitivity, specificity, PPV and NPV of USG compared to histopathology was 88.2%; 61.5%; 75% and 80% respectively. Sensitivity, specificity, PPV and NPV of MRI compared to histopathology was 100%; 92.8%; 84.1% and 100% respectively. On comparison, MRI had better diagnostic accuracy than USG MRI is a very sensitive imaging modality for the evaluation of female patients with suspected or confirmed adnexal masses and disease extent is better evaluated than ultrasonography.
A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study

Olivier Lucidarme,Jean-Paul Akakpo,Seth Granberg,Mario Sideri,Hanoch Levavi,Achim Schneider,Philippe Autier,Dror Nir,Harry Bleiberg,for the Ovarian HistoScanning Clinical Study Group,

DOI: https://doi.org/10.1007/s00330-010-1750-6

IF: 7.034

2010-03-20

European Radiology

Abstract:ObjectivesTo prospectively assess an innovative computer-aided diagnostic technology that quantifies characteristic features of backscattered ultrasound and theoretically allows transvaginal sonography (TVS) to discriminate benign from malignant adnexal masses.MethodsWomen (n = 264) scheduled for surgical removal of at least one ovary in five centres were included. Preoperative three-dimensional (3D)-TVS was performed and the voxel data were analysed by the new technology. The findings at 3D-TVS, serum CA125 levels and the TVS-based diagnosis were compared with histology. Cancer was deemed present when invasive or borderline cancerous processes were observed histologically.ResultsAmong 375 removed ovaries, 141 cancers (83 adenocarcinomas, 24 borderline, 16 cases of carcinomatosis, nine of metastases and nine others) and 234 non-cancerous ovaries (107 normal, 127 benign tumours) were histologically diagnosed. The new computer-aided technology correctly identified 138/141 malignant lesions and 206/234 non-malignant tissues (98% sensitivity, 88% specificity). There were no false-negative results among the 47 FIGO stage I/II ovarian lesions. Standard TVS and CA125 had sensitivities/specificities of 94%/66% and 89%/75%, respectively. Combining standard TVS and the new technology in parallel significantly improved TVS specificity from 66% to 92% (p < 0.0001).ConclusionsComputer-aided quantification of backscattered ultrasound is a highly sensitive for the diagnosis of malignant ovarian masses.

radiology, nuclear medicine & medical imaging
[Differential diagnosis of cystic adnexa processes. A comparison of the value of sonography, puncture cytology and color and biochemical biopsy analysis with histology]

B Christensen,J Hoffmann,K A Metz,A E Schindler

Abstract:The histological diagnoses of 109 cystic adnexal masses were compared with the results of ultrasound examination, color, cytology and biochemical analyses of cystic fluid. In cases with suspicious results by ultrasound examination most of the malignant tumors but only a small number of benign cystic masses were found. Macroscopic and cytologic examinations gave no further informations. By biochemical analyses functional cysts could be detected with 86% of sensitivity and 100% of specificity by a combination of estradiol, progesterone and Ca 12-5. Endometrioma and malignant tumors could be separated from other adnexal masses (specificity 95%, sensitivity 100%) with a combination of Tag 72-4 and CASA.
Contrast-enhanced Ultrasonography for Differential Diagnosis of Adnexal Masses.

Weihui Shentu,Yin Zhang,Jiaojiao Gu,Fa Wang,Wei Zhao,Chunmei Liu,Zimei Lin,Yao Wang,Chen Liu,Yunyu Chen,Qiyun Fan,Hongying Wang

DOI: https://doi.org/10.3389/fonc.2022.968759

IF: 4.7

2022-01-01

Frontiers in Oncology

Abstract:BackgroundQuantitative contrast-enhanced ultrasonography parameters are affected by various factors. We evaluated corrected quantitative contrast enhanced ultrasonography in differentiating benign adnexal tumors from malignant tumors.MethodsPatients with adnexal masses who underwent conventional and contrast-enhanced ultrasonography were included. Contrast-enhanced ultrasonography parameters such as base intensity, arrival time, peak intensity, time to peak intensity, ascending slope, and descending slope were measured. Corrected (time to peak intensity − arrival time) mass/(time to peak intensity − arrival time) uterus and (peak intensity − base intensity) mass/(peak intensity − base intensity) uterus were calculated. Lesions were confirmed by pathologic examination of surgical specimens.ResultsThis study included 31 patients with 35 adnexal lesions including 20 (57.10%) benign and 15 (42.90%) malignant lesions. The corrected contrast-enhanced ultrasonography quantitative parameters in lesions were statistically different between malignant and benign groups (P<0.05). The optimal cut-off value for (time to peak intensity − arrival time) mass/(time to peak intensity − arrival time) uterus, ascending slope, and (peak intensity − base intensity) mass/(peak intensity − base intensity) uterus, and descending slope for differentiating malignant adnexal masses from benign tumors were 1.05 (area under curve: 0.93, P<0.05), 1.11 (area under curve: 0.83, P<0.05), 0.82 (area under curve: 0.73, P<0.05), and −0.27 (area under curve: 0.66, P=0.16), with sensitivity and specificity of 93.33% and 85.00%, 86.67% and 75.00%, 86.67% and 60.00%, and 54.55% and 66.67%, respectively.ConclusionsCorrected contrast-enhanced ultrasonography parameters provide practical differential diagnosis value of adnexal lesions with high reliability for sonologists.
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid ultrasound morphology

F Moro,M Vagni,H E Tran,F Bernardini,F Mascilini,F Ciccarone,C Nero,D Giannarelli,L Boldrini,A Fagotti,G Scambia,L Valentin,A C Testa

DOI: https://doi.org/10.1002/uog.27680

2024-05-15

Abstract:Objective: Our primary aim was to identify radiomic ultrasound features that can distinguish benign from malignant adnexal masses with solid ultrasound morphology, and primary invasive from metastatic solid ovarian masses, and to develop ultrasound-based machine learning models that include radiomics features to discriminate between benign and malignant solid adnexal masses. Our secondary aim was to compare the diagnostic performance of our radiomics models with that of the ADNEX model and subjective assessment by an experienced ultrasound examiner. Methods: This is a retrospective observational single center study. Patients with a histological diagnosis of an adnexal tumor with solid morphology at preoperative ultrasound examination performed between 2014 and 2021 were included. The patient cohort was split into training and validation sets with a ratio of 70:30 and with the same proportion of benign and malignant (borderline, primary invasive and metastatic) tumors in the two subsets. The extracted radiomic features belonged to two different families: intensity-based statistical features and textural features. Models to predict malignancy were built based on a random forest classifier, fine-tuned using 5-fold cross-validation over the training set, and tested on the held-out validation set. The variables used in model building were patient's age, and those radiomic features that were statistically significantly different between benign and malignant adnexal masses (Wilcoxon-Mann-Whitney Test with Benjamini-Hochberg correction for multiple comparisons) and assessed as not redundant based on the Pearson correlation coefficient. We describe discriminative ability as area under the receiver operating characteristics curve (AUC) and classification performance as sensitivity and specificity. Results: 326 patients were identified and 775 preoperative ultrasound images were analyzed. 68 radiomic features were extracted, 52 differed statistically significantly between benign and malignant tumors in the training set, and 18 features were selected for inclusion in model building. The same 52 radiomic features differed statistically significantly between benign, primary invasive malignant and metastatic tumors. However, the values of the features manifested overlap between primary malignant and metastatic tumors and did not differ statistically significantly between them. In the validation set, 25/98 tumors (25.5%) were benign, 73/98 (74.5%) were malignant (6 borderline, 57 primary invasive, 10 metastases). In the validation set, a model including only radiomics features had an AUC of 0.80, and 78% sensitivity and 76% specificity at its optimal risk of malignancy cutoff (68% based on Youden's index). The corresponding results for a model including age and radiomics features were 0.79, 86% and 56% (cutoff 60% based on Youden's method), while those of the ADNEX model were 0.88, 99% and 64% (at 20% malignancy cutoff). Subjective assessment had sensitivity 99% and specificity 72%. Conclusions: Even though our radiomics models had discriminative ability inferior to that of the ADNEX model, our results are promising enough to justify continued development of radiomics analysis of ultrasound images of adnexal masses. This article is protected by copyright. All rights reserved.
Comparison of ultrasound−based ADNEX model with magnetic resonance imaging for discriminating adnexal masses: a multi-center study

Yanli Hu,Bo Chen,Hongmei Dong,Bo Sheng,Zhibo Xiao,Jia Li,Wei Tian,Furong Lv

DOI: https://doi.org/10.3389/fonc.2023.1101297

IF: 4.7

2023-04-25

Frontiers in Oncology

Abstract:Objectives: The ADNEX model offered a good diagnostic performance for discriminating adnexal tumors, but research comparing the abilities of the ADNEX model and MRI for characterizing adnexal tumors has not been reported to our knowledge. The aim of this study was to evaluate the diagnostic accuracy of the ultrasound-based ADNEX (Assessment of Different NEoplasias in the adneXa) model in comparison with that of magnetic resonance imaging (MRI) for differentiating benign, borderline and malignant adnexal masses. Methods: This prospective study included 529 women with adnexal masses who underwent assessment via the ADNEX model and subjective MRI analysis before surgical treatment between October 2019 and April 2022 at two hospitals. Postoperative histological diagnosis was considered the gold standard. Results: Among the 529 women, 92 (17.4%) masses were diagnosed histologically as malignant tumors, 67 (12.7%) as borderline tumors, and 370 (69.9%) as benign tumors. For the diagnosis of malignancy, including borderline tumors, overall agreement between the ADNEX model and MRI pre-operation was 84.9%. The sensitivity of the ADNEX model of 0.91 (95% confidence interval [CI]: 0.85–0.95) was similar to that of MRI (0.89, 95% CI: 0.84–0.94; P =0.717). However, the ADNEX model had a higher specificity (0.90, 95% CI: 0.87–0.93) than MRI (0.81, 95% CI: 0.77–0.85; P =0.001). The greatest sensitivity (0.96, 95% CI: 0.92–0.99) and specificity (0.94, 95% CI: 0.91–0.96) were achieved by combining the ADNEX model and subjective MRI assessment. While the total diagnostic accuracy did not differ significantly between the two methods ( P =0.059), the ADNEX model showed greater diagnostic accuracy for borderline tumors ( P <0.001). Conclusion: The ultrasound-based ADNEX model demonstrated excellent diagnostic performance for adnexal tumors, especially borderline tumors, compared with MRI. Accordingly, we recommend that the ADNEX model, alone or with subjective MRI assessment, should be used for pre-operative assessment of adnexal masses.

oncology
Comparison of the Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses

Le Qian,Qinwen Du,Meijiao Jiang,Fei Yuan,Hui Chen,Weiwei Feng

DOI: https://doi.org/10.3389/fonc.2021.673722

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:Aim This study aimed to compare different ultrasound-based International Ovarian Tumor Analysis (IOTA) prediction models, namely, the Simple Rules (SRs) the Assessment of Different NEoplasias in the adneXa (ADNEX) models, and the Risk of Malignancy Index (RMI), for the pre-operative diagnosis of adnexal mass. Methods This single-centre diagnostic accuracy study involved 486 patients. All ultrasound examinations were analyzed and the prediction models were applied. Pathology was the clinical reference standard. The diagnostic performances of prediction models were measured by evaluating receiver-operating characteristic curves, sensitivities, specificities, positive and negative predictive values, positive and negative likelihood ratios, and diagnostic odds ratios. Results To discriminate benign and malignant tumors, areas under the ROC curves (AUCs) for ADNEX models were 0.94 (95% CI: 0.92–0.96) with CA125 and 0.94 (95% CI: 0.91–0.96) without CA125, which were significantly higher than the AUCs for RMI I-III: 0.87 (95% CI: 0.83–0.90), 0.83 (95% CI: 0.80–0.86), and 0.82 (95% CI: 0.78–0.86), (all P < 0.0001). At a cut-off of 10%, the ADNEX model with CA125 had the highest sensitivity (0.93; 95% CI: 0.87–0.97) compared with the other models. The SRs model achieved a sensitivity of 0.93 (95% CI: 0.86–0.97) and a specificity of 0.86 (95% CI: 0.82–0.89) when inconclusive diagnoses (11.7%) were classified as malignant. Conclusion ADNEX and SRs models were excellent at characterising adnexal masses which were superior to the RMI in Chinese patients.
Imaging in gynecological disease (18): clinical and ultrasound characteristics of urinary bladder malignancies

J. Knez,F. Nardelli,T. Bosch,P. Sladkevicius,L. Valentin,D. Jurkovic

DOI: https://doi.org/10.1002/uog.21958

2020-09-01

Ultrasound in Obstetrics and Gynecology

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To describe clinical and ultrasound characteristics of urinary bladder malignancies diagnosed on transvaginal ultrasound in women presenting with suspected gynecological problems</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This is a multicenter retrospective study of women with histological diagnosis of urinary bladder malignancy that was suspected on transvaginal ultrasound examination. The cases were collected from three centers which specialize in the use of pelvic ultrasound between January 2007 and October 2018. Clinical data were obtained from the computer databases and all tumor images were assessed by two authors (DJ and JK) to look for characteristic sonographic patterns. We have compared the characteristics of tumors seen in women presenting with symptoms suspicious of urinary bladder malignancy and those without such symptoms.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Thirty women with a confirmed diagnosis of urinary bladder malignancy on histological examination were included. Median age at diagnosis was 70.5 years (range 36‐88). The most common presenting symptom was postmenopausal bleeding which was recorded in 18 women (60%). Ten women (33%) had symptoms suspicious of bladder malignancy: six had unexplained visible hematuria, three had unexplained recurrent urinary tract infections and one woman had dysuria and microhematuria. On histological examination 23 women (77%) were diagnosed with primary bladder malignancy whilst seven women (23%) had metastases in the bladder from other primary tumors. Out of 23 primary tumors, 21 (91%) were of urothelial origin (12 low‐grade and 9 high‐grade). Most low‐grade urothelial carcinomas appeared on ultrasound as irregular papillary growth (11/12, 92%) and they were moderately to highly vascular on color Doppler examination (8/12, 67%). The ultrasound appearances of primary non‐urothelial and metastatic tumors varied without a clear common morphological tumor pattern. The tumors found in women with symptoms suggestive of bladder malignancy did not differ unequivocally from those detected in other women in their size, ultrasound morphology, vascularity or histological type.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Urinary bladder malignancies can be detected in patients undergoing transvaginal ultrasound examination for suspected gynecological problems. Primary urothelial cancers have relatively uniform morphological pattern, whilst the appearances of other bladder malignancies are more variable.</p><p>This article is protected by copyright. All rights reserved.</p></section>

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Diagnostic Value of Contrast‐Enhanced Ultrasound in Benign and Malignant Adnexal Masses

Boyang Zhang,Xiao Han

DOI: https://doi.org/10.1002/jum.16580

2024-09-25

Journal of Ultrasound in Medicine

Abstract:In the diagnosis of gynecological tumors, determining the benign or malignant nature of adnexal masses is a crucial and complex issue. Contrast‐enhanced ultrasound (CEUS) is a relatively novel and increasingly used diagnostic method. Therefore, this study evaluated the diagnostic value of CEUS in differentiating benign and malignant adnexal masses through meta‐analysis and systematic review. We systematically searched PubMed, Embase, Web of Science, and the Cochrane Library for studies published up to April 2024 regarding the use of CEUS in diagnosing benign and malignant adnexal masses. STATA 14.0 software was used for data analysis, pooling the sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (DOR) of eligible studies. After initial screening, 305 studies were identified, 13 of which met the inclusion criteria and were analyzed in this meta‐analysis. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and DOR of CEUS for the diagnosis of benign and malignant adnexal masses were 0.92 (95% confidence interval [CI]: 0.88–0.95), 0.88 (95% CI: 0.82–0.93), 8.00 (95% CI: 5.00–12.90), 0.09 (95% CI: 0.06–0.14), and 91.00 (95% CI: 45.00–185.00), respectively. The area under the summary receiver operating characteristic curve (AUC) was 0.95 (95% CI: 0.93–0.97). CEUS is a noninvasive, nonradiative imaging modality with high accuracy and reliability in the diagnosis of benign and malignant adnexal masses. To provide an effective adjunct tool in the clinic, future studies can further explore the specific application value of CEUS and its performance in different populations.

radiology, nuclear medicine & medical imaging,acoustics

Use of daclizumab in the immunosuppression of high-risk kidney and kidney/pancreas recipients: Warsaw Transplantation Center experience.

Postoperative Mortality in Cancer Patients With Preexisting Diabetes

Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification

Imaging techniques for the pre-surgical diagnosis of adnexal tumours

Adnexal Masses in Pregnancy: A Single-Centre Prospective Observational Cohort Study

Imaging Evaluation of Ovarian Masses

Evaluating use of IOTA two‐step strategy to classify adnexal masses identified in pregnancy: pilot study

Endometriomas: their ultrasound characteristics

Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound

EP23.19: Diagnostic accuracy of ultrasound scoring systems in differentiating benign versus malignant adnexal masses

Agreement between frozen section and histopathology to detect malignancy in adnexal masses according to size and morphology by ultrasound

The research and application of the optimization technique of continuous annealing line temper mill roll contour

Role of ultrasonography, magnetic resonance imaging in evaluation of female pelvic masses with histopathological correlation

A new computer-aided diagnostic tool for non-invasive characterisation of malignant ovarian masses: results of a multicentre validation study

[Differential diagnosis of cystic adnexa processes. A comparison of the value of sonography, puncture cytology and color and biochemical biopsy analysis with histology]

Contrast-enhanced Ultrasonography for Differential Diagnosis of Adnexal Masses.

Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid ultrasound morphology

Comparison of ultrasound−based ADNEX model with magnetic resonance imaging for discriminating adnexal masses: a multi-center study

Comparison of the Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses

Imaging in gynecological disease (18): clinical and ultrasound characteristics of urinary bladder malignancies

Diagnostic Value of Contrast‐Enhanced Ultrasound in Benign and Malignant Adnexal Masses